Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 02, 2015 6:42 PM ET

Healthcare Providers and Services

Company Overview of New York Blood Center, Inc.

Company Overview

New York Blood Center, Inc. operates as a community-based non-profit blood collection and distribution organization in the United States. It offers various blood products and services, such as whole blood components, autologous and directed donation, frozen blood and rare blood, aphaeresis, clinical aphaeresis services, leukaphaeresis, cell salvage, hematopoietic stem cells, and immunohematology and genomics laboratory services to hospitals in New York, New Jersey, Hudson Valley, Long Island, and parts of Connecticut and Pennsylvania. The company also provides transfusion products and medical services, including bone marrow services, medical consultation, professional education, hemophilia s...

310 East 67th Street

New York, NY 10021

United States

Founded in 1964





Key Executives for New York Blood Center, Inc.

Chief Executive Officer, President and Trustee
Chief Financial Officer and Senior Vice President
Chief Operating Officer and Senior Vice President
Vice President, General Counsel and Secretary
Chief Medical Officer, Senior Vice President and Trustee
Compensation as of Fiscal Year 2015.

New York Blood Center, Inc. Key Developments

New York Blood Center Announces New Collaboration with the University of California, Davis to Manufacture Specialized Lines of Stem Cells

New York Blood Center (NYBC) announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease. Under the two-year agreement, UC Davis will produce induced pluripotent stem cells (iPSCs) from homozygous units from New York Blood Center's umbilical cord blood bank. Cord blood units contain adult stem cells collected from umbilical cord blood donations after the birth and safe delivery of a baby. NYBC's rare collection of homozygous units presents a unique opportunity to make iPSC lines that will be capable of making any human tissue and being matched to a large number of people. This will allow for vast new opportunities for future clinical use.

New York Blood Center, Inc. Announces Executive appointments

New York Blood Center, Inc. announced that Mr. Schmidtlein and former CBC board member Stephen Wurtzler will join the company's board.

Similar Private Companies By Industry

Company Name Region
Dearborn County Hospital United States
All-American Care Centers, Inc. United States
Sheridan Emergency Physician Services Of South Carolina, P.A. United States
Hero Management, LLC United States
Pinnacle Medical Group, P.A. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact New York Blood Center, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at